Pacific Channel has a highly experienced team of professionals with expertise in preparing companies for investment and in securing funds. We also help companies fill executive roles and provide guidance on governance, as required.
Management Team
Brent S. Ogilvie, BSc. (Bio.), MBA
Managing Director
bogilvie AT pacificchannel DOT com
Tel: +64 9 304 0868
Mr Brent Ogilvie is the Founder and Managing Director of Pacific Channel Limited.
Foundation CEO (Part-time) and Director of Androgenix Limited, a biotechnology company developing fertility technologies with application in the world-wide livestock industry.
Director of Ecodiesel Limited, which has developed a proprietary manufacturing process to convert tallow (purified animal fat) into biodiesel at a capital cost several-fold lower and at a lower operating cost than known alternative processes.
Director of S1 Limited, which as Somnaceutics successfully developed and sold the intellectual property of a sleep-enhancement tonic and its other business assets to an NZX-listed company:
Director of Breathe Easy Limited, which is developing a therapeutic for cystic fibrosis.
Director of SciTOX Limited, which is commercialising a bio-sensor based toxicity analysis device.
Trustee of the Urban Eco-living Trust, which teaches New Zealand youth about sustainable living through a mobile-learning centre.
Former New Zealand Consul & Trade Commissioner to New York – Life Sciences.
Former industrial product manager for a global corporation; consultant to New Zealand start-ups.
_____________________________________________
Dr Robert G. Feldman, BSc, MB, BS, MSc, PhD
Executive Director
robert.feldman AT pacificchannel DOT com
Tel: +64 9 304 0867
Dr Robert Feldman is an Executive Director at Pacific Channel Limited
Medical Doctor and PhD in microbiology/immunology
Consults to New Image Group to support sales and further development of ‘Sleep Time’, a sleep enhancement natural tonic that was developed by Somnaceutics Limited, a Pacific Channel seed company which was acquired by New Image in December 2010.
Consults to Indigix, a United Kingdom-based company developing a technology to modify immunological responses.
15 years experience in the biotechnology and healthcare sectors.
Founder/CEO/Senior VP of 5 companies including Microscience Ltd, Vmax Ltd, Riotech Pharmaceuticals Ltd., Paramount BioScience Inc. and FirstPoint Biotech Inc.
Operational, strategic, fundraising and business development experience.
_____________________________________________
Mitali Purohit, BSc. (Bio.), MBE. (Hons)
Associate
mitali.purohit AT pacificchannel DOT com
Tel: +64 9 304 0866
Mitali Purohit is an Associate at Pacific Channel Limited
Through Pacific Channel’s activities as a seed investor, Ms. Purohit serves as a Chief Operating Officer for Breathe Easy Ltd, a biotechnology company that is developing a treatment for Cystic Fibrosis.
Investment Representative on the NZBio/ATEED Regional (Auckland) Committee.
Investment Representative on The Lighthouse Platform Sector Engagement Group.
Ms Purohit has experience in assessing investment opportunities and assisting early-stage life-science and engineering-based ventures to become investment ready.
Ms Purohit’s principal interest is in technology commercialization, especially opportunity analysis, marketing and business development.
Her Master’s thesis, which was completed under the commercial supervision of Pacific Channel prior to her employment, investigated ingredient co-branding as a strategy option for a New Zealand supplier of functional ingredients.